Neuroblastoma Treatment Market - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015- 2021
- Submitted by: davidmoore
- Views: 93
- Category: Science
- Date Submitted: 08/04/2016 04:23 AM
- Pages: 3
- Report this Essay
Published By:Zion Market Research
Neuroblastoma Treatment Market - Global Industry Perspective,
Comprehensive Analysis and Forecast, 2015- 2021
Contact Us:
4283, Express Lane, Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +1-386-310-3803 GMT
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
sales@zionmarketresearch.com
Neuroblastoma Treatment Market
Neuroblastoma (NB) is the most common cancer in childhood and infancy. Neuroblastoma is a
cancer that starts in primitive nerve cells. It rarely occurs after age around 10 years. Neuroblastoma
is sometimes caused by a gene mutation passed from the parent to the child. It commonly start in the
adrenal glands, it usually grows into a large, firm mass that presses other organs. It can also develop
in nerves near the backbone and in the spinal cord, neck, chest, or abdomen. Some of the most
common symptoms of the neuroblastoma are firm mass in the abdomen, enlarged stomach, weight,
anemia, crankiness, fever, bone pain, bulging eyes, dark circles around the eyes, weakness, and high
blood pressure.
A range of therapeutics or drugs has been adopted to treat the metastatic neuroblastoma such as
immunotherapy, and chemotherapy. The neuroblastoma treatment market is mainly driven by the
rising incidences of cancer worldwide. Growing healthcare expenses is another key factor to drive the
neuroblastoma market. However, some issues like high cost treatment is expected to hamper growth
of neuroblastoma treatment market. U.S. shows incidence of around 650 cases every year.
Neuroblastoma Treatment Market
Browse the full “Neuroblastoma Treatment Market - Global Industry Perspective,
Comprehensive Analysis and Forecast, 2015- 2021" report
at https://www.zionmarketresearch.com/report/neuroblastoma-treatment-market
Combination chemotherapy and ch14.18 monoclonal antibody therapy,vaccine therapy,
lenalidomide and ch14.18 monoclonal antibody therapy with or without...
Neuroblastoma Treatment Market - Global Industry Perspective,
Comprehensive Analysis and Forecast, 2015- 2021
Contact Us:
4283, Express Lane, Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +1-386-310-3803 GMT
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
sales@zionmarketresearch.com
Neuroblastoma Treatment Market
Neuroblastoma (NB) is the most common cancer in childhood and infancy. Neuroblastoma is a
cancer that starts in primitive nerve cells. It rarely occurs after age around 10 years. Neuroblastoma
is sometimes caused by a gene mutation passed from the parent to the child. It commonly start in the
adrenal glands, it usually grows into a large, firm mass that presses other organs. It can also develop
in nerves near the backbone and in the spinal cord, neck, chest, or abdomen. Some of the most
common symptoms of the neuroblastoma are firm mass in the abdomen, enlarged stomach, weight,
anemia, crankiness, fever, bone pain, bulging eyes, dark circles around the eyes, weakness, and high
blood pressure.
A range of therapeutics or drugs has been adopted to treat the metastatic neuroblastoma such as
immunotherapy, and chemotherapy. The neuroblastoma treatment market is mainly driven by the
rising incidences of cancer worldwide. Growing healthcare expenses is another key factor to drive the
neuroblastoma market. However, some issues like high cost treatment is expected to hamper growth
of neuroblastoma treatment market. U.S. shows incidence of around 650 cases every year.
Neuroblastoma Treatment Market
Browse the full “Neuroblastoma Treatment Market - Global Industry Perspective,
Comprehensive Analysis and Forecast, 2015- 2021" report
at https://www.zionmarketresearch.com/report/neuroblastoma-treatment-market
Combination chemotherapy and ch14.18 monoclonal antibody therapy,vaccine therapy,
lenalidomide and ch14.18 monoclonal antibody therapy with or without...